Regulation 46 of the LODR
Financials - Quarterly Results
Financial Year 2024-2025
Quarter 1 FY24-25
Financial Year 2023-2024
Quarter 4 FY23-24
Quarter 3 FY23-24
Quarter 2 FY23-24
Quarter 1 FY23-24
Financial Year 2022-2023
Quarter 4 FY22-23
Quarter 3 FY22-23
Quarter 2 FY22-23
Quarter 1 FY22-23
Financial Year 2021-2022
Quarter 4 FY21-22
Quarter 3 FY21-22
Quarter 2 FY21-22
Quarter 1 FY21-22
Financial Year 2020-2021
Quarter 4 FY20-21
Quarter 3 FY20-21
Quarter 2 FY20-21
Quarter 1 FY20-21
Financial Year 2019-2020
Quarter 4 FY19-20
Quarter 3 FY19-20
Quarter 2 FY19-20
Quarter 1 FY19-20
Subsidiary Financials
Financial Year 2023-2024
Financial Year 2022-2023
Financial Year 2021-2022
Financial Year 2020-2021
Financial Year 2019-2020
Financial Year 2018-2019
Annual Reports
Year 2023-24
Year 2022-23
Year 2021-22
Year 2020-21
Year 2019-20
Year 2018-19
Corporate Announcements
Board of Directors
Dr. Sushil Shah is the Chairman Emeritus of Metropolis Healthcare Limited. Beckoned by a strong academic career, Dr. Shah embarked upon his educational journey with the prestigious Scindia School and went onto completing his M.B.B.S in 1972 and M.D. in Pathology and Bacteriology from Grant Medical College in 1975. In 1978, he received Research Fellowship at the esteemed Cornell Medical Centre in Endocrine Pathology. Thereon, he held many prestigious academic positions and headed departments at recognised hospitals throughout his career. He has headed the RIA department at Breach Candy Hospital and Pathology Departments at Sir. H.N. Hospital, Saifee Hospital and Cumballa Hill Hospital. He has numerous scientific publications to his credit and has pioneered Radio Immunoassay Technique, HIV testing and In-Vitro Fertilisation for the first time in India. He also served as a PhD teacher in Microbiology at Mumbai University in 2004 and PhD/MSc Guide by Research at Rai University in Mumbai.
Inundated with business acumen, Dr. Shah displays an exemplary mix of academic and business success. In addition to the evident accomplishments to his credit as the founder of Metropolis Healthcare, he has held Directorial positions at leading corporates. A businessman of wide understanding, Dr. Shah was the Director at Dr. Reddy’s Laboratories and Span Diagnostics, the Executive Director of Dr. Reddy’s Diagnostic and Standard Finance Equity Fund. His Entrepreneurial zeal, disposition and accomplishments made him the Ernst and Young’s Entrepreneur of the Year in 2011.
An alumni of the prestigious Scindia School, Dr. Shah was felicitated with the esteemed ‘Madhav Award as an Old Boy of Eminence’ for the year 2016 for his exemplary business acumen coupled with deep commitment to Corporate Social Responsibility and outstanding contribution in the medical field. For his contributions, he has earned national recognitions like the Rashtriya Chikitsa Ratna Award, Rajiv Gandhi Gold Medal Award and also is a Member of the Committee on Diagnostics with the FDA and Research Committee of IICB, Calcutta. Dr Shah was also awarded the prestigious Maharashtra Gaurav Award for his contributions to the state of Maharashtra. In addition, he was honoured with the prestigious Lifetime Achievement Award by Six Sigma Healthcare Awards. He has been felicitated with the Hurun Industry Achievement Award for the year 2022 in the Diagnostics Category and Hurun Star of Mumbai Awards by Hurun India.
Authored by Maya Bathija, a biography on Dr. Sushil Shah titled “Dare to Make a Change” was released by Rupa Publishers in 2022. The book “Dare to Make a Change” gives us a sneak view inside Dr. Shah’s journey, life, vision, and the foresight that made Metropolis possible while being honest and integrity.
Dr. Shah has made significant contributions to the overall Diagnostic Pathology Industry and continues his pursuit towards a vision of a consolidated Industry in India.
Ms. Ameera Sushil Shah has been a Director on our board since 2008. A global thought leader in the healthcare industry, she has played an instrumental role in changing the pathology industry landscape in the country; from being a doctor led practice to a professional corporate group in an extremely unregulated, competitive, and fragmented market.
Over the two decades, Ms. Shah has built the organization across the board, and has been a dynamic driving force behind the entire corporate transformation and the sustained growth of Metropolis. Due to its unique growth model and competitive advantage, Metropolis has attracted three rounds of investment by reputed private equity investors. Under the leadership of Ms. Shah, Metropolis listed successfully at the stock exchanges in 2019 and within three years of its listing, the company cemented a position of trust with international and domestic investors by posting industry leading performance every quarter and delivering good returns on their investments. Upholding the highest standards of corporate governance and business ethics, Metropolis has built exceptional value for all its stakeholders.
Ms. Ameera Shah is the recipient of the Entrepreneur of the Year Award in healthcare category for the year 2021 from Ernst & Young. She has been named amongst ‘Asia’s Power Businesswoman’ (2020) by Forbes Asia, ‘Fifty Most Powerful Women in Business’ by Fortune India (2017, 2018, 2019, 2020, 2021) and Business Today (2018, 2019, 2021, 2022). She has been bestowed with multiple awards for her outstanding performance & excellence in diagnostics business and entrepreneurship from various reputed organizations.
Ms. Ameera Shah is an eminent industry spokesperson and has been a speaker in various National and International forums, industry events and conclaves. She has been an active member & has served senior level positions in key industry bodies that drives policy decisions at the Center. She is currently serving as the Sr. Vice-President of NATHealth (Healthcare Federation of India).
Ms. Shah is an independent director on the board of reputed Indian companies (Torrent Pharma, Adani Group), Prior to the Pandemic, she was an advisor to Baylor College of Medicine, Texas and the global advisory board of AXA, a Paris headquartered company with 700 Billion $ under asset management.
Mr. Vivek Gambhir is currently associated with Imagine Marketing India Private Limited (BoAt Lifestyle). Prior to joining BoAt Lifestyle, he worked with Godrej Consumer Products Limited and Godrej Industries & its associate companies. He was also a founding member of Bain’s consulting operations in India and led the firm’s FMCG practice in India. He has more than ten years of experience in operations and strategy. He has been a Director on our Board since September 2018.
Mr. Vivek holds a Bachelor’s degree in both Science and Arts from Lafayette College, Pennsylvania and Master’s degree in Business Administration from Harvard University.
Mr. Sanjay Bhatnagar has served as the Chairman of the American Chamber of Commerce in India and as a Board member of the US India Strategic Partnership Forum. Prior to joining the Company, he has worked with Enron India Private Limited, WaterHealth International Inc. and the THOT Capital Group LLC. He has more than 16 years of experience in project development, marketing, and operation management. He has been a Director on our Board since 2018.
Mr. Sanjay holds a Master’s degree in Engineering from Stanford University and Business Administration from Harvard University.
Ms. Anita Ramachandran began her career in the Management Consultancy division of AF Ferguson & Co (the KPMG network company in India then) in Mumbai in 1976 as the first woman consultant in the firm and worked in a wide range of areas from finance, industrial market research, strategy, and human resources consulting. She founded M/s. Cerebrus Consultants in the year 1995 to focus on HR advisory services, which has now established itself as a specialist firm in the HR field. Anita has worked with over 350 companies in South Asia on a range of HR issues. Her wide general management consulting experience and insights into HR have enabled her to be a strategic advisor to many family groups. She supports many organizations in the social sector through pro bono professional work and remains deeply committed to working with women.
Ms. Anita brings over 40 years of extensive experience as a Management Consultant. She holds an MBA with a specialization in Finance from the Jamnalal Bajaj Institute of Management Studies (JBIMS) in Mumbai.
Mr. Hemant Sachdev is a BA in Political Science from Delhi and an alumnus of Harvard Business School. He is a first-generation entrepreneur and has more than two decades of experience. He has business interests in Retail, Distribution and Education.
Mr. Subramanian Ranganathan, a seasoned corporate professional with nearly four decades of exemplary experience in Finance and Management, is the Independent Director of the Company. He is a qualified Chartered Accountant, Company Secretary, and Cost Accountant. He also holds an LL. B in General Law.
Mr. Subramanian Ranganathan is known for his customer-focused approach and has significantly contributed to corporate profitability. He excels in navigating through stressful situations to achieve strategic goals and possesses outstanding communication and negotiating skills. His adeptness at stakeholder engagement, both internal and external, is evident from his proven track record of effective advocacy with regulators and government bodies. As a self-starter and team builder, he has held senior positions in various companies, demonstrating a remarkable ability to cut through organizational ambiguities to provide clear focus and direction.
Currently, Mr. Subramanian Ranganathan is affiliated with K. S. Aiyar & Co., Chartered Accountants as a Partner (Banking, Finance & Insurance.) Previously, he held the position of Managing Director at ECL Finance Limited, within the Edelweiss Group and President & Group CFO at Edelweiss Financial Services Limited. Prior to his tenure at Edelweiss, he held leadership positions in multinational companies such as Bank of America – Merrill Lynch, Citibank NA, and Citicorp Finance Limited.
Dr. Aparna Rajadhyaksha has over 20 years of extensive experience in the medical field, coupled with a robust educational background. She holds an M.D. and M.B.B.S. degree from the University of Mumbai, D.Y. Patil Medical College, Mumbai, India, with specialized training in Clinical Pathology from Tufts University, Baystate Medical Center, and Medical Genetics from the University of Miami. Additionally, she has an Executive MBA from the Quantic School of Business and Technology.
Throughout her career, Dr. Rajadhyaksha has held key positions such as Director of Cytogenetics and Molecular Genetics at Vitro Molecular Laboratory in Miami, and Internal Quality Assurance and Quality Control Manager at Mass General Hospital in Boston. She has also served as Medical Director at Nicklaus Children’s Hospital and eviCore Healthcare. Currently, she has been serving as a Senior Medical Consultant at Metropolis Healthcare Limited for over four years and holds the position of Medical Director at Noridian Healthcare Solutions, LLC.
Code Of Conduct & Policies
Code Of Conduct & Policies
Metropolis Healthcare Limited
Composition of Board & Committees
Submission To Stock Exchange
Financial Year 2024-2025
FY24-25 Quarter 1
Financial Year 2023-2024
FY23-24 Quarter 4
FY23-24 Quarter 3
FY23-24 Quarter 2
FY23-24 Quarter 1
Financial Year 2022-2023
FY22-23 Quarter 4
FY22-23 Quarter 3
FY22-23 Quarter 2
FY22-23 Quarter 1
Financial Year 2021-2022
FY21-22 Quarter 4
FY21-22 Quarter 3
FY21-22 Quarter 2
FY21-22 Quarter 1
Financial Year 2020-2021
FY20-21 Quarter 4
FY20-21 Quarter 3
FY20-21 Quarter 2
FY20-21 Quarter 1
Financial Year 2019-2020
FY19-20 Quarter 4
FY19-20 Quarter 3
FY19-20 Quarter 2
FY19-20 Quarter 1
Financial Year 2018-2019
FY18-19 Quarter 4
Quarter 3 Disclosures
Quarter 2 Disclosures
Quarter 1 Disclosures
Contact details for Investors
Contact Details
Contact details for Investor Grievance Redressal
Ms. Ameera Shah
Executive Chairperson and Whole-time Director
4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai - 400030, Maharashtra, India.
Telephone: (91 22) 6258 2860
E-mail ID: investor.relations@metropolisindia.com
Mr. Surendran Chemmenkotil
Chief Executive Officer
4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai - 400030, Maharashtra, India.
Telephone: (91 22) 6258 2860
E-mail ID: investor.relations@metropolisindia.com
Mr. Rakesh Agarwal
Chief Financial Officer
4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai - 400030, Maharashtra, India.
Telephone: (91 22) 6258 2860
E-mail ID: investor.relations@metropolisindia.com
Mr. Kamlesh Kulkarni
Head - Legal & Secretarial
4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai - 400030, Maharashtra, India.
Telephone: (91 22) 6258 2860
E-mail ID: investor.relations@metropolisindia.com
Contact details of the Registrar and Transfer Agent
M/s. Link Intime India Private Limited
C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai – 400083.
Telephone: (91 22) 4918 6200
Facsimile: (91 22) 4918 6195
Investor grievance e-mail: metropolis.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Unclaimed Dividend
Unclaimed Dividend 2020-21
FY21-22
FY20-21
FY19-20